Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Éva Szabó is active.

Publication


Featured researches published by Éva Szabó.


Neuropharmacology | 2011

Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease

Attila Kovacs; Angelika Saje; Andrew Wong; Gábor Szénási; Péter Kiricsi; Éva Szabó; Jonathan D. Cooper; David A. Pearce

Mutations in the CLN3 gene cause juvenile Batten disease, a fatal pediatric neurodegenerative disorder. The Cln3-knockout (Cln3(Δex1-6)) mouse model of the disease displays many pathological characteristics of the human disorder including a deficit in motor coordination. We have previously found that attenuation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)-type glutamate receptor activity in one-month-old Cln3(Δex1-6) mice resulted in an immediate improvement of their motor skills. Here we show that at a later stage of the disease, in 6-7-month-old Cln3(Δex1-6) mice, acute inhibition of AMPA receptors by a single intraperitoneal injection (1mg/kg) of the non-competitive AMPA antagonist, EGIS-8332, does not have an immediate effect. Instead, it induces a delayed but prolonged improvement of motor skills. Four days after the injection of the AMPA antagonist, Cln3(Δex1-6) mice reached the same motor skill level as their wild type (WT) counterparts, an improvement that persisted for an additional four days. EGIS-8332 was rapidly eliminated from the brain as measured by HPLC-MS/MS. Histological analysis performed 8 days after the drug administration revealed that EGIS-8332 did not have any impact upon glial activation or the survival of vulnerable neuron populations in 7-month-old Cln3(Δex1-6) mice. We propose that temporary inhibition of AMPA receptors can induce a prolonged correction of the pre-existing abnormal glutamatergic neurotransmission in vivo for juvenile Batten disease.


Journal of Medicinal Chemistry | 2011

Optimization of (Arylpiperazinylbutyl)oxindoles Exhibiting Selective 5-HT7 Receptor Antagonist Activity

Balázs Volk; Istvan Gacsalyi; Katalin Pallagi; László Poszávácz; Ildikó Gyönös; Éva Szabó; Tibor Bakó; Michael Spedding; Gyula Simig; Gábor Szénási

A series of (arylpiperazinylbutyl)oxindoles as highly potent 5-HT(7) receptor antagonists has been studied for their selectivity toward the 5-HT(1A) receptor and α(1)-adrenoceptor. Several derivatives exhibited high 5-HT(7)/5-HT(1A) selectivity, and the key structural factors for reducing undesired α(1)-adrenergic receptor binding have also been identified. Rapid metabolism, a common problem within this family of compounds, could be circumvented with appropriate substitution patterns on the oxindole carbocycle. Contrary to expectations, none of the compounds produced an antidepressant-like action in the forced swimming test in mice despite sufficiently high brain concentrations. On the other hand, certain analogues showed significant anxiolytic activity in two different animal models: the Vogel conflict drinking test in rats and the light-dark test in mice.


Journal of Pharmaceutical and Biomedical Analysis | 1988

Computer-aided spectrophotometric determination of multicomponent drugs☆

Judit Géher; Éva Szabó

The conditions of least squares deconvolution by linear combination have been investigated in three-component systems. The significant effects of the main factors, the lack of significant interactions and the linear relationship of absorbance with the concentration of each component were established by using a 2(3) factorial experiment design and by evaluating the results with a three-way analysis of variance. The content of active ingredients of three-component injections was determined by means of computer-aided evaluation of UV-spectra in systems that fulfilled these conditions.


European Journal of Pharmacology | 2015

A novel GABAA alpha 5 receptor inhibitor with therapeutic potential

István Ling; Balázs Mihalik; Lori An Etherington; Gábor Kapus; Adrienn Pálvölgyi; Gabor Gigler; Szabolcs Kertesz; Attila Gaál; Katalin Pallagi; Péter Kiricsi; Éva Szabó; Gábor Szénási; Lilla Papp; Laszlo Gabor Harsing; György Lévay; Michael Spedding; Jeremy J. Lambert; Delia Belelli; Jozsef Barkoczy; Balázs Volk; Gyula Simig; Istvan Gacsalyi; Ferenc Antoni

Novel 2,3-benzodiazepine and related isoquinoline derivatives, substituted at position 1 with a 2-benzothiophenyl moiety, were synthesized to produce compounds that potently inhibited the action of GABA on heterologously expressed GABAA receptors containing the alpha 5 subunit (GABAA α5), with no apparent affinity for the benzodiazepine site. Substitutions of the benzothiophene moiety at position 4 led to compounds with drug-like properties that were putative inhibitors of extra-synaptic GABAA α5 receptors and had substantial blood-brain barrier permeability. Initial characterization in vivo showed that 8-methyl-5-[4-(trifluoromethyl)-1-benzothiophen-2-yl]-1,9-dihydro-2H-[1,3]oxazolo[4,5-h][2,3]benzodiazepin-2-one was devoid of sedative, pro-convulsive or motor side-effects, and enhanced the performance of rats in the object recognition test. In summary, we have discovered a first-in-class GABA-site inhibitor of extra-synaptic GABAA α5 receptors that has promising drug-like properties and warrants further development.


Journal of Molecular Catalysis B-enzymatic | 2002

Baker's yeast mediated preparation of (10-alkyl-10H-phenothiazin-3-yl)methanols

Monica Ioana Toşa; Csaba Paizs; Cornelia Majdik; Paula Moldovan; Lajos Novák; Pál Kolonits; Éva Szabó; László Poppe; Florin Dan Irimie

Abstract A series of 10-alkyl-10H-phenothiazine-3-carbaldehydes (2a–h) were obtained by Vilsmeier–Haack formylation from the corresponding 10-alkyl-10H-phenothiazines (1a–h) and reduced to (10-alkyl-10H-phenothiazine-3-yl)methanols (3a–h) by two alternative methods. The baker’s yeast catalyzed reaction proved to be superior over the NaBH4 reduction and yielded the desired 3-hydroxymethylphenothiazines (3a–h) almost quantitatively.


Journal of Clinical Densitometry | 2018

A Valid and Precise Semiautomated Method for Quantifying INTERmuscular Fat INTRAmuscular Fat in Lower Leg Magnetic Resonance Images

Andy Kin On Wong; Éva Szabó; Marta Erlandson; Marshall S. Sussman; Sravani Duggina; Anny Song; Shannon Reitsma; Hana Gillick; Jonathan D. Adachi; Angela M. Cheung

The accumulation of INTERmuscular fat and INTRAmuscular fat (IMF) has been a hallmark of individuals with diabetes, those with mobility impairments such as spinal cord injuries and is known to increase with aging. An elevated amount of IMF has been associated with fractures and frailty, but the imprecision of IMF measurement has so far limited the ability to observe more consistent clinical associations. Magnetic resonance imaging has been recognized as the gold standard for portraying these features, yet reliable methods for quantifying IMF on magnetic resonance imaging is far from standardized. Previous investigators used manual segmentation guided by histogram-based region-growing, but these techniques are subjective and have not demonstrated reliability. Others applied fuzzy classification, machine learning, and atlas-based segmentation methods, but each is limited by the complexity of implementation or by the need for a learning set, which must be established each time a new disease cohort is examined. In this paper, a simple convergent iterative threshold-optimizing algorithm was explored. The goal of the algorithm is to enable IMF quantification from plain fast spin echo (FSE) T1-weighted MR images or from water-saturated images. The algorithm can be programmed into Matlab easily, and is semiautomated, thus minimizing the subjectivity of threshold-selection. In 110 participants from 3 cohort studies, IMF area measurement demonstrated a high degree of reproducibility with errors well within the 5% benchmark for intraobserver, interobserver, and test-retest analyses; in contrast to manual segmentation which already yielded over 20% error for intraobserver analysis. This algorithm showed validity against manual segmentations (r > 0.85). The simplicity of this technique lends itself to be applied to fast spin echo images commonly ordered as part of standard of care and does not require more advanced fat-water separated images.


Journal of Pharmaceutical and Biomedical Analysis | 2017

Charged derivatization and on-line solid phase extraction to measure extremely low cortisol and cortisone levels in human saliva with liquid chromatography–tandem mass spectrometry

Balázs Magda; Zoltán Dobi; Katalin Mészáros; Éva Szabó; Zoltán Márta; Tímea Imre; Pál Szabó

&NA; The aim of this study was to develop a sensitive, reliable and high‐throughput liquid chromatography – electrospray ionization – mass spectrometric (LC‐ESI–MS/MS) method for the simultaneous quantitation of cortisol and cortisone in human saliva. Derivatization with 2‐hydrazino‐1‐methylpyridine (HMP) was one of the most challenging aspects of the method development. The reagent was reacting with cortisol and cortisone at 60 °C within 1 h, giving mono‐ and bis‐hydrazone derivatives. Investigation of derivatization reaction and sample preparation was detailed and discussed. Improvement of method sensitivity was achieved with charged derivatization and use of on‐line solid phase extraction (on‐line SPE). The lower limit of quantitation (LLOQ) was 5 and 10 pg/ml for cortisol and cortisone, respectively. The developed method was subsequently applied to clinical laboratory measurement of cortisol and cortisone in human saliva. Graphical abstract Figure. No caption available. HighlightsDifficulties of the sample preparation and derivatization were solved during method development.On‐line solid phase extraction was used due to the high sample volume injection.LC–MS/MS method with charged derivatization and on‐line SPE was developed to quantify cortisol and cortisone in human saliva.


Archive | 1993

Process for the preparation of 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2[3H]-one

Jozsef Reiter; Peter Trinka; Peter Tompe; Éva Szabó; Péter Slégel; Janos Brlik; Agnes Halbauer nee Nagy; Ilona Sztruhar; Magdolna Kenyeres nee Feher; Frigyes Gorgenyi; Margit Csorgo; Szvetlana Zsarnoczai nee Kurnyecova; Sarolta Benko nee Markus; Gabor Gigler; Dezsö Danyi; Pal Fekete; Maria Kiraly nee Ignacz


Archive | 1992

Process for and 2-(cyanoimino)-quinazoline derivatives useful as intermediates in the preparation of 6,7-di-(chloro)-1,5-di(hydro)-imidazo-[2,1-b]quinazolin-2[3H]-one and process for preparing the 2-(cyanoimino)-quinazoline derivatives

Józef Dr. Reiter; Peter Trinka; Peter Tompe; Éva Szabó; Péter Slégel; Janos Brlik; Agnes Halbauer; Ilona Sztruhar; Magdolna Kenyeres; Frigyes Gorgenyi; Margit Csorgo; Szvetlana Zsarnúczai; Sarolta Benkö; Gabor Gigler; Dezsö Danyi; Pal Fekete; Mária Király


European Journal of Organic Chemistry | 1992

Synthesis of Novel HMG-CoA Reductase Inhibitors, I. Naphthalene Analogs of Mevinolin

Lajos Novák; János Rohály; László Poppe; Gábor Hornyánszky; Pál Kolonits; István Zelei; Imre Fehér; Jeno Fekete; Éva Szabó; Uwe Záhorszky; András Jávor; Csaba Szántay

Collaboration


Dive into the Éva Szabó's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lajos Novák

Budapest University of Technology and Economics

View shared research outputs
Top Co-Authors

Avatar

Pál Kolonits

Budapest University of Technology and Economics

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Balázs Volk

Hungarian Academy of Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge